ACM
CLBT icon

Ashford Capital Management’s Cellebrite CLBT Stock Holding History

Ashford Capital Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.3M Buy
1,762,937
+92,092
+6% +$1.39M 3% 7
2025
Q4 		$30.1M Sell
1,670,845
-29,440
-2% -$529K 3.36% 7
2025
Q3 		$31.5M Buy
1,700,285
+434,615
+34% +$6.83M 3.51% 5
2025
Q2 		$20.3M Buy
1,265,670
+27,830
+2% +$496K 2.38% 14
2025
Q1 		$24.1M Sell
1,237,840
-612,840
-33% -$12.9M 3.1% 9
2024
Q4 		$40.8M Sell
1,850,680
-38,530
-2% -$742K 4.81% 1
2024
Q3 		$31.8M Sell
1,889,210
-15,070
-0.8% -$224K 3.97% 2
2024
Q2 		$22.8M Buy
1,904,280
+63,040
+3% +$704K 3.07% 12
2024
Q1 		$20.4M Buy
1,841,240
+350,140
+23% +$3.57M 2.76% 14
2023
Q4 		$12.9M Buy
+1,491,100
New +$11.6M 1.73% 24

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ashford Capital Management's CLBT Position: Q1 2026 in Review

Ashford Capital Management increased its Cellebrite (CLBT) stake by 5.5% in Q1 2026, buying an estimated $1.39M and bringing the position to 1,762,937 shares worth $24.3M. The position accounts for 3% of the portfolio, ranked #7.

Ashford Capital Management first reported a position in CLBT in Q4 2023 and has held it in 10 quarters since. The position peaked at $40.8M in Q4 2024. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Ashford Capital Management held 1,762,937 shares of Cellebrite worth $24.3M as of Q1 2026.
  • Ashford Capital Management bought 92,092 Cellebrite shares in Q1 2026, an estimated $1.39M.
  • Cellebrite made up 3% of Ashford Capital Management's portfolio in Q1 2026, its #7 holding.
  • Ashford Capital Management first reported a position in Cellebrite in Q4 2023 and has held it in 10 quarters since.
  • Ashford Capital Management's Cellebrite position peaked at $40.8M in Q4 2024.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Ashford Capital Management's 13F filing for Q1 2026, filed 15 May 2026.